Eosinophilic Asthma Resource Centre

Welcome, this website is intended for all international healthcare professionals. By clicking the link below you are declaring and confirming that you are a healthcare professional.

You are here

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

Sally Wenzel, Mario Castro, Jonathan Corren, Jorge Maspero, Lin Wang, et al.

Lancet 2016;388:31-44

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre.

Search this site

ERS 2017 Congress Highlights

Featured Video Presentation

Share